{
    "organizations": [],
    "uuid": "6d92ad72f6009258b2d0b5c8c96851983cc4b1b7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cellectar-receives-uspto-notice-of/brief-cellectar-receives-uspto-notice-of-allowance-for-patent-covering-use-of-clr-131-in-multiple-myeloma-idUSFWN1PX19S",
    "ord_in_thread": 0,
    "title": "BRIEF-Cellectar Receives USPTO Notice Of Allowance For Patent Covering Use Of CLR 131 In Multiple Myeloma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Cellectar Biosciences Inc:\n* CELLECTAR RECEIVES USPTO NOTICE OF ALLOWANCE FOR PATENT COVERING USE OF CLR 131 IN MULTIPLE MYELOMA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-07T21:30:00.000+02:00",
    "crawled": "2018-02-09T06:06:02.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cellectar",
        "bioscience",
        "inc",
        "cellectar",
        "receives",
        "uspto",
        "notice",
        "allowance",
        "patent",
        "covering",
        "use",
        "clr",
        "multiple",
        "myeloma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}